Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3, signaling a behind-the-scenes software update. There are no indicated changes to study content or visible functionality based on the provided data.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates an update to the site’s underlying system or template, without changing the study details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now states that no participants are being recruited anymore and updates the study duration references to up to 54 months. New sections for How to Read a Study Record, Common Questions, and How to Join a Study are added, and the Intervention/Treatment details are expanded.SummaryDifference0.9%

- Check41 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor platform update.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision tag v3.5.4 was added, replacing the previous v3.5.3. This indicates the page has been updated to a newer revision.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, signaling a version update. This update is a technical patch and does not change the study data or presented content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.